Journal
DIAGNOSTICS
Volume 8, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics8010005
Keywords
graphene; electrochemical biosensors; cancer; diagnosis; electrical detection; Alzheimer's disease; dementia; neurodegenerative disorders; cardiovascular; blood biomarkers; antibodies; proteins
Categories
Funding
- UK's Engineering and Physical Sciences Research Council (EPSRC) [EP/M006301/1]
- University of Plymouth [GD105227]
- Engineering and Physical Sciences Research Council [EP/M006301/1] Funding Source: researchfish
- EPSRC [EP/M006301/1] Funding Source: UKRI
Ask authors/readers for more resources
We report on the development of label-free chemical vapour deposition (CVD) graphene field effect transistor (GFET) immunosensors for the sensitive detection of Human Chorionic Gonadotropin (hCG), a glycoprotein risk biomarker of certain cancers. The GFET sensors were fabricated on Si/SiO2 substrate using photolithography with evaporated chromium and sputtered gold contacts. GFET channels were functionalised with a linker molecule to an immobile anti-hCG antibody on the surface of graphene. The binding reaction of the antibody with varying concentration levels of hCG antigen demonstrated the limit of detection of the GFET sensors to be below 1 pg/mL using four-probe electrical measurements. We also show that annealing can significantly improve the carrier transport properties of GFETs and shift the Dirac point (Fermi level) with reduced p-doping in back-gated measurements. The developed GFET biosensors are generic and could find applications in a broad range of medical diagnostics in addition to cancer, such as neurodegenerative (Alzheimer's and Parkinson's) and cardiovascular disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available